For Doctors in a Hurry
- Clinicians lack evidence regarding whether genicular artery embolization effectively treats pain in patients with mild to moderate knee osteoarthritis.
- This randomized controlled trial followed 58 patients assigned to receive either the embolization procedure or a sham intervention.
- At 12 months, the between-group difference in pain scores was not statistically significant, with a p-value of 0.25.
- The researchers concluded that both groups experienced equal pain reduction, indicating that the procedure provides no additional therapeutic benefit.
- These findings suggest that observed pain relief is primarily placebo-driven and do not support implementing this procedure in clinical practice.
Evaluating the Clinical Role of Genicular Artery Embolization
Knee osteoarthritis remains a leading cause of global disability, frequently leaving clinicians with limited options for patients who fail conservative management but are not yet candidates for total joint arthroplasty [1]. To address this gap, genicular artery embolization has emerged as a minimally invasive intervention targeting abnormal synovial neovascularization (the formation of new, pathological blood vessels) associated with chronic joint pain and inflammation [2, 3, 4]. While early observational data suggested that reducing this hypervascularity could improve patient-reported outcomes, the evidence base has been characterized by significant heterogeneity in procedural techniques and embolic materials [5, 6]. Furthermore, the lack of robust, long-term comparative data against sham procedures has made it difficult to distinguish therapeutic efficacy from the substantial placebo response often seen in osteoarthritis trials [2, 7, 8, 9]. A recent randomized controlled trial of 58 patients found that between-group differences in pain scores at 12 months were not statistically significant (7.46; 95% CI: -13.63 to 28.56; p = 0.25), suggesting that long-term symptomatic relief may be largely driven by the placebo effect [7]. These findings indicate that while the procedure is technically feasible, its clinical implementation for mild to moderate osteoarthritis requires further validation [7, 10].
Trial Design and Patient Selection
To evaluate the long-term efficacy of genicular artery embolization, researchers conducted a randomized controlled trial focusing on patients diagnosed with mild to moderate knee osteoarthritis. The primary objective was to determine if the procedure is more effective in relieving pain symptoms after 12 months when compared directly to a sham intervention. This study design addressed a critical gap in orthopedic literature by utilizing a control group to account for the psychological and physiological effects of the surgical process itself, which can often confound results in pain management trials. The study enrolled a total of 58 patients who had previously demonstrated a lack of clinical improvement following conservative treatment options, such as physical therapy or pharmacological management. These participants were randomly assigned to one of two cohorts to ensure a balanced comparison of outcomes. The genicular artery embolization group consisted of 29 patients, while the sham treatment group also included 29 patients. By maintaining these equal treatment arms, the researchers sought to isolate the specific therapeutic impact of arterial embolization from the baseline improvements often observed in patients receiving specialized clinical attention.
Assessment of Pain and Synovial Inflammation
The researchers established a rigorous longitudinal follow-up schedule to track the clinical trajectory of both patient cohorts, conducting assessments at 1, 4, 8, and 12 months post-procedure. While the primary endpoint focused on long-term pain relief, a secondary aim was to investigate changes in synovitis (inflammation of the synovial membrane that lines the joint capsule) observed at 4 months. The study sought to determine if any observed reductions in joint lining inflammation correlated with other clinical outcomes, providing a biological context for the patient-reported symptoms. To quantify these symptoms, the researchers utilized the Knee Injury and Osteoarthritis Outcome Score (a validated survey measuring pain, symptoms, and quality of life). This standardized instrument allowed for a multidimensional assessment of how the intervention affected daily function and patient well-being. In addition to these subjective measures, the study employed objective imaging to monitor the physical state of the joint. Synovitis was imaged using contrast-enhanced MRI at baseline, 1 month, and 4 months, which provided high-resolution data on the vascularity and inflammatory status of the synovial tissue following the embolization procedure. The analysis of these repeated measurements over the one-year study period required a specialized statistical approach to maintain accuracy. The researchers compared outcomes using generalized estimating equations (a statistical method used to analyze longitudinal data where measurements are correlated over time). This methodology allowed the team to account for the relationship between a single patient's data points across multiple follow-up visits, ensuring that the comparison between the genicular artery embolization group and the sham group remained statistically robust throughout the 12-month duration.
Equivalence in Long-Term Clinical Outcomes
The longitudinal analysis of patient-reported outcomes revealed that both cohorts experienced improvements in pain levels over the 12-month study period, though the magnitude of change was comparable between the two arms. In the genicular artery embolization group, pain scores improved from a baseline of 44.44 (95% CI: 38.87 to 50.02) to 65.61 (95% CI: 57.16 to 74.06) at the one-year mark. Similarly, the sham group demonstrated an improvement from 42.34 (95% CI: 36.45 to 48.22) at baseline to 58.15 (95% CI: 48.7 to 67.6) after 12 months. Despite these numerical increases in both arms, the between-group difference in pain scores after 12 months was 7.46 (95% CI: −13.63 to 28.56; p = 0.25), indicating that the intervention did not provide a statistically significant benefit over the sham procedure. Beyond subjective pain measures, the researchers found that the physiological markers of joint inflammation remained largely unchanged following the intervention. There were no significant within-group changes for synovitis, and the data further showed no significant between-group changes for synovitis throughout the follow-up period. Because patients undergoing genicular artery embolization and sham treatment both demonstrated an equal sustained pain reduction at 12 months follow-up, the findings suggest that the perceived benefits of the procedure are likely attributable to a robust and lasting placebo effect. Ultimately, there were no differences in synovitis reduction or other clinical outcomes between the groups, leading the authors to conclude that the current evidence does not support the clinical implementation of genicular artery embolization for patients with mild to moderate knee osteoarthritis.
Evidence Against Clinical Implementation
The longitudinal data from this randomized controlled trial indicate that the improvements observed in patients undergoing genicular artery embolization are not superior to those achieved through a sham intervention. While both groups reported higher Knee Injury and Osteoarthritis Outcome Scores at the one-year mark, the between-group difference of 7.46 (95% CI: −13.63 to 28.56; p = 0.25) confirms that the procedure lacks a specific therapeutic effect. Because the reduction in pain was statistically equivalent across both arms of the study, the results suggest a sustained placebo effect in the long term. This finding is particularly relevant for clinicians, as it demonstrates that the perceived benefits of the procedure can persist for at least 12 months despite the absence of a measurable physiological impact on the joint environment. Furthermore, the lack of objective improvement in joint health reinforces the argument against adopting this procedure in standard practice. The researchers found no differences in synovitis reduction or other clinical outcomes between the genicular artery embolization and sham groups, and contrast-enhanced MRI showed no significant within-group or between-group changes for synovial inflammation. Given that the intervention failed to provide superior results compared to the sham in either subjective pain relief or objective imaging markers, the authors conclude that the findings do not support the clinical implementation of genicular artery embolization as a treatment for patients with mild to moderate knee osteoarthritis. For the practicing physician, these results suggest that the current evidence is insufficient to justify the risks and costs associated with this invasive intervention for this specific patient population.
References
1. Rodríguez-Reyes D, Vargas-Figueroa RA, Vázquez-Lloret AS, Martinez H, González-Díaz G, Ortiz RS. Nonoperative Management Recommendations for Knee Osteoarthritis: A Review of Clinical Guidelines and Treatment Alternatives. Cureus. 2025. doi:10.7759/cureus.95540
2. Mohammad A, Milhem F, Takhman M, et al. Abstract 4349153: Genicular Artery Embolization for Knee Osteoarthritis: A Systematic Review of Sham-Controlled Randomized Trials. Circulation. 2025. doi:10.1161/circ.152.suppl_3.4349153
3. Fawzy NA, Tahir MJ, Arabi TZ, et al. Safety and Efficacy of Genicular Artery Embolization for Knee Joint Osteoarthritis Associated Pain: A Systematic Review. Journal of Endovascular Therapy. 2025. doi:10.1177/15266028251326770
4. Guevara-Noriega KA, Chavez-Abiega R, Castro-Rios JG. Embolization of genicular arteries in patients with knee osteoarthritis as an alternative for refractory pain treatment: A systematic review.. Medicina clinica. 2022. doi:10.1016/j.medcli.2022.07.022
5. Bolsegui ML, Ghozy S, Kobeissi H, Kadirvel R, Kallmes DF, Thompson SM. Common Design, Data Elements and Core Outcome Measures Reported on Clinical Trials of Genicular Artery Embolization for Knee Osteoarthritis: An Interactive Systematic Review.. Academic radiology. 2024. doi:10.1016/j.acra.2023.08.029
6. Chlorogiannis D, Vasilopoulou A, Konstantinidis CI, Pagona AE, Filippiadis DK. Knee pain improvement after genicular artery embolization for the management of knee osteoarthritis: an updated systematic review and meta-analysis of 21 studies.. Radiologie (Heidelberg, Germany). 2024. doi:10.1007/s00117-024-01388-9
7. Zadelhoff TAV, Heijden RAVD, Bierma-Zeinstra SMA, Bos PK, Oei EHG. Long-term outcomes of genicular artery embolization for knee osteoarthritis: 12-month efficacy and secondary outcomes from a randomized sham-controlled clinical trial.. European radiology. 2026. doi:10.1007/s00330-026-12505-8
8. González-Hernández Y, Hernández-Yumar A, Armas-Castellano AD, et al. PD124 Genicular Artery Embolization For The Treatment Of Knee Osteoarthritis: A Systematic Review And Meta-analysis. International Journal of Technology Assessment in Health Care. 2024. doi:10.1017/S0266462324003611
9. Landers S, Hely R, Hely A, et al. Genicular artery embolization for early-stage knee osteoarthritis: results from a triple-blind single-centre randomized controlled trial. Bone & Joint Open. 2023. doi:10.1302/2633-1462.43.bjo-2022-0161.r2
10. Hernández-Yumar A, González‐Hernández Y, Pino‐Sedeño TD, et al. Genicular artery embolization for knee osteoarthritis: a systematic review with meta-analysis and cost-analysis. Gaceta Sanitaria. 2025. doi:10.1016/j.gaceta.2025.102459
